ӳ����ý

An analysis of nearly 3,800 colorectal cancer patients — the largest germline risk study for this cancer to date — reveals opportunities for improved risk screening and, possibly, treatment.

Researchers have identified an indirect way of countering a key genetic lesion in neuroblastoma.

A new computational tool merges cancer genome and protein interaction data to find cancer-fueling mutations more effectively.

Expanded agreement will focus on identifying three new drugs for novel oncology targets

Expanded “connectivity map” creates more than 1.3 million gene expression profiles of drug treatment and genetic perturbation, accelerating research on small molecules and gene function.

Improved methods validate the use of blood samples for studying patients’ cancer genomes

Coinciding with the second anniversary of the breakthrough patient-driven research movement, this first of many data releases aims to accelerate progress in metastatic breast cancer research.

The ӳ����ý Cancer Dependency Map team adds CRISPR-based data from 342 cancer cell lines to their growing catalog of genetic dependencies in cancer, and a new method for ensuring that data's accuracy.